QQ客服 官方微博 反馈留言

浏览/检索结果: 共13条，第1-10条 帮助 限定条件 发表日期：2017    专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer 期刊论文 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 卷号: 110, 页码: 51-61 作者:  Li, Xin;  Yang, Changyong;  Wan, Hong;  Zhang, Ge;  Feng, Jun 收藏  |  浏览/下载：136/0  |  提交时间：2019/01/08 Pyrotinib  HER2-postive breast cancer  Irreversible EGFR/HER2 dual tyrosine kinase  inhibitor  Preclinical  Clinical  Safety  Drug metabolism   Cyanobacterial peptides as a prototype for the design of cathepsin D inhibitors 期刊论文 JOURNAL OF PEPTIDE SCIENCE, 2017, 卷号: 23, 期号: 9, 页码: 701-706 作者:  Xu, Hao;  Bao, Keting;  Tang, Shuai;  Ai, Jing;  Hu, Haiyan 收藏  |  浏览/下载：26/0  |  提交时间：2019/01/08 cathepsin D  inhibitor  peptides  structural modification  transition-state mimics   Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 35, 页码: 59086-59102 作者:  Zhang, Xuesai;  Li, Qingrou;  Zhao, Hui;  Ma, Lanping;  Meng, Tao 收藏  |  浏览/下载：33/0  |  提交时间：2019/01/08 tissue factor  triple negative breast cancer  pancreatic adenocarcinoma  metastasis  antibody-drug conjugate   Ginsenoside Rd regulates the Akt/mTOR/p70S6K signaling cascade and suppresses angiogenesis and breast tumor growth 期刊论文 Oncology reports, 2017, 卷号: 38, 期号: 1, 页码: 359-367 作者:  Zhang, Eryun;  Shi, Hailian;  Yang, Li;  Wu, Xiaojun;  Wang, Zhengtao 收藏  |  浏览/下载：20/0  |  提交时间：2019/01/08 Programmed Multiresponsive Vesicles for Enhanced Tumor Penetration and Combination Therapy of Triple-Negative Breast Cancer 期刊论文 ADVANCED FUNCTIONAL MATERIALS, 2017, 卷号: 27, 期号: 20 作者:  Zhou, Fangyuan;  Feng, Bing;  Wang, Tingting;  Wang, Dangge;  Meng, Qingshuo 收藏  |  浏览/下载：31/0  |  提交时间：2019/01/08 Discovery of novel BRD4 inhibitors by high-throughput screening, crystallography, and cell-based assays 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 卷号: 27, 期号: 9, 页码: 2003-2009 作者:  Sun, Zhongya;  Zhang, Hao;  Chen, Zhifeng;  Xie, Yiqian;  Jiang, Hao 收藏  |  浏览/下载：89/0  |  提交时间：2019/01/08 BRD4 inhibitor  High-throughput screening  Crystallography   Albumin Biomimetic Nanocorona Improves Tumor Targeting and Penetration for Synergistic Therapy of Metastatic Breast Cancer 期刊论文 ADVANCED FUNCTIONAL MATERIALS, 2017, 卷号: 27, 期号: 11 作者:  Cao, Haiqiang;  Zou, Lili;  He, Bin;  Zeng, Lijuan;  Huang, Yongzhuo 收藏  |  浏览/下载：24/0  |  提交时间：2019/01/08 Emerging and Diverse Functions of the EphA2 Noncanonical Pathway in Cancer Progression 期刊论文 Biological & pharmaceutical bulletin, 2017, 卷号: 40, 期号: 10, 页码: 1616-1624 作者:  Zhou, Yue;  Sakurai, Hiroaki 收藏  |  浏览/下载：9/0  |  提交时间：2019/01/08 Smart nanoparticles improve therapy for drug resistant tumors by overcoming pathophysiological barriers 期刊论文 ACTA PHARMACOLOGICA SINICA, 2017, 卷号: 38, 期号: 1, 页码: 1-8 作者:  Liu, Jian-ping;  Wang, Ting-ting;  Wang, Dang-ge;  Dong, An-jie;  Li, Ya-ping 收藏  |  浏览/下载：26/0  |  提交时间：2019/01/08 solid tumors  chemotherapy  drug resistance  pathophysiological barriers  tumor microenvironment  nanomedicine  smart nanoparticles   Anticancer Drug Combinations, How Far We can Go Through? 期刊论文 ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 卷号: 17, 期号: 1, 页码: 21-28 作者:  Lu, Da-Yong;  Chen, En-Hong;  Wu, Hong-Ying;  Lu, Ting-Ren;  Xu, Bin 收藏  |  浏览/下载：23/0  |  提交时间：2019/01/08 Drug combination  drug resistance  neoplasm metastasis  biotherapy  cancer stem cell  personalized cancer therapy